|
🐜
|
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma.
30 auth.
M. Cavo,
L. Pantani,
M. Petrucci,
F. Patriarca,
E. Zamagni,
D. Donnarumma,
C. Crippa,
M. Boccadoro,
G. Perrone,
A. Falcone,
C. Nozzoli,
R. Zambello,
L. Masini,
A. Furlan,
A. Brioli,
...
D. Derudas,
S. Ballanti,
M. Dessanti,
V. De Stefano,
A. Carella,
M. Marcatti,
A. Nozza,
F. Ferrara,
V. Callea,
C. Califano,
A. Pezzi,
A. Baraldi,
M. Grasso,
P. Musto,
A. Palumbo
|
8 |
2012 |
8
🐜
|
|
🐜
|
A retrospective study on 73 elderly patients (≥75years) with aggressive B-cell non Hodgkin lymphoma: clinical significance of treatment intensity and comprehensive geriatric assessment.
15 auth.
F. Marchesi,
N. Cenfra,
L. Altomare,
M. Dessanti,
S. Mecarocci,
E. Cerchiara,
A. Rago,
M. D'Andrea,
V. Tomarchio,
O. Olimpieri,
...
M. Tirindelli,
A. Mengarelli,
M. Petti,
G. Avvisati,
G. Cimino
|
5 |
2013 |
5
🐜
|
|
🐜
|
Hepatitis C virus infection prevalence and liver dysfunction in a cohort of B-cell non-Hodgkin's lymphoma patients treated with immunochemotherapy
8 auth.
L. Nosotti,
M. D'andrea,
A. Pitidis,
F. Pimpinelli,
M. Dessanti,
F. Pisani,
...
P. Vignally,
M. Petti
|
4 |
2012 |
4
🐜
|
|
🐜
|
Evaluation of risk of symptomatic cytomegalovirus reactivation in myeloma patients treated with tandem autologous stem cell transplantation and novel agents: a single‐institution study
11 auth.
F. Marchesi,
F. Pimpinelli,
M. Dessanti,
S. Gumenyuk,
F. Palombi,
F. Pisani,
...
A. Romano,
A. Spadea,
M. Maschio,
F. Ensoli,
A. Mengarelli
|
4 |
2014 |
4
🐜
|
|
🐜
|
The potential role of pre‐transplant HBcIgG seroposivity as predictor of clinically relevant cytomegalovirus infection in patients with lymphoma undergoing autologous hematopoietic stem cell transplantation: A study from the Rome Transplant Network
16 auth.
F. Marchesi,
F. Giannotti,
G. Avvisati,
M. Petti,
F. Pimpinelli,
P. Paba,
M. Dessanti,
R. Cerretti,
M. Tirindelli,
A. Picardi,
...
M. D'Andrea,
A. Spadea,
F. Ensoli,
C. Perno,
A. Mengarelli,
W. Arcese
|
3 |
2012 |
3
🐜
|
|
🐜
|
Standard‐ versus high‐dose lenograstim in adults with hematologic malignancies for peripheral blood progenitor cell mobilization
15 auth.
A. Romeo,
A. Chierichini,
A. Spagnoli,
M. Vittori,
M. Vacca,
M. Gozzer,
A. Spadea,
B. Anaclerico,
M. Dessanti,
M. D'Andrea,
...
G. Toglia,
L. Annino,
M. Petti,
A. Mengarelli,
W. Arcese
|
3 |
2010 |
3
🐜
|
|
🐜
|
Comparison between biosimilar filgrastim vs other granulocyte‐colony stimulating factor formulations (originator filgrastim, peg‐filgrastim and lenograstim) after autologous stem cell transplantation: a retrospective survey from the Rome Transplant Network
14 auth.
F. Marchesi,
E. Cerchiara,
M. Dessanti,
S. Gumenyuk,
L. Franceschini,
F. Palombi,
F. Pisani,
A. Romano,
A. Spadea,
L. Pupo,
...
O. Annibali,
Antonella La Malfa,
W. Arcese,
A. Mengarelli
|
3 |
2015 |
3
🐜
|
|
🐜
|
Trigeminal neuralgia as unusual isolated symptom of fungal paranasal sinusitis in patients with haematological malignancies
10 auth.
Marta Maschio,
A. Mengarelli,
Corrado Girmenia,
A. Vidiri,
Ramy Kayal,
M. T. Gallo,
...
Grazia Prignano,
M. Dessanti,
M. D'Andrea,
M. Petti
|
3 |
2012 |
3
🐜
|
